XML 17 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Income (Loss) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Net sales $ 2,167.4 $ 1,440.0 $ 1,074.4
Cost of products sold 1,729.8 1,109.7 766.1
Gross profit 437.6 330.3 308.3
Selling expense 74.2 46.7 36.9
Research and development expense 26.6 20.3 13.8
General expense 266.1 169.9 116.9
Total nonmanufacturing expenses 366.9 236.9 167.6
Restructuring and impairment expense 19.3 10.1 11.9
Operating profit 51.4 83.3 128.8
Interest expense 86.1 46.1 30.5
Other income (expense), net 10.3 35.9 (1.0)
Income (Loss) before income taxes and income from equity affiliates (24.4) 73.1 97.3
Income tax expense (benefit) (12.6) (9.4) 18.4
Income from equity affiliates, net of income taxes 5.2 6.4 4.9
Net income (loss) (6.6) 88.9 83.8
Dividends (0.9) (0.6) (0.7)
Undistributed earnings available to Common Stockholders, basic 0.0 (0.5) (0.4)
Less: Undistributed earnings available to participating securities, Diluted 0.0 (0.5) (0.4)
Undistributed and distributed earnings (loss) available to common stockholders, basic (7.5) 87.8 82.7
Undistributed and distributed earnings (loss) available to common stockholders, diluted $ (7.5) $ 87.8 $ 82.7
Net income per share:      
Basic (in dollars per share) $ (0.18) $ 2.83 $ 2.68
Diluted (in dollars per share) $ (0.18) $ 2.80 $ 2.66
Weighted average shares outstanding:      
Basic (in shares) 42,442,200 31,030,400 30,832,700
Diluted (in shares) 42,442,200 31,400,300 31,104,200